Evaluation of Vitamin C for Adjuvant Sepsis Therapy

Antioxidants and Redox Signaling

Volumn 19, Issue 17, 2013, Pages 2129-2140

  Wilson, John X ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALBUMIN; AMINO ACID; ANGIOTENSIN II; ANTIOXIDANT; BETA CAROTENE; BUPRENORPHINE; DEHYDROASCORBIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FERRITIN; GUANYLATE CYCLASE; HYDROGEN PEROXIDE; HYPERTENSIVE FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NORADRENALIN; OCCLUDIN; OKADAIC ACID; PERITONEAL DIALYSIS FLUID; PEROXYNITRITE; PHOSPHOPROTEIN PHOSPHATASE 2A; PLASMA PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SELENIUM; TYROSINE; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; ZINC;

ADJUVANT THERAPY; CRITICALLY ILL PATIENT; DEATH; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SAFETY; EDEMA; EXTRAVASATION; FLUID RESUSCITATION; HUMAN; HYPOTENSION; INFLAMMATION; INJURY; INOTROPISM; INTERSTITIAL FLUID; KLEBSIELLA PNEUMONIAE; MICROVASCULAR ENDOTHELIAL CELL; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NITRATION; NONHUMAN; OXIDATION; PARENTERAL NUTRITION; PERMEABILITY BARRIER; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; SEPSIS; SEPTIC SHOCK; VASODILATATION;

ANIMALS; ANTICOAGULANTS; ASCORBIC ACID; BLOOD COAGULATION; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; MICROVESSELS; SEPSIS;

EID: 84886432847     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5401     Document Type: Review

References (68)

1. Alkharfy KM, Kellum JA, and Matzke GR. Unintended immunomodulation: part II. Effects of pharmacological agents on cytokine activity. Shock 13: 346-360, 2000.
2. Armour J, Tyml K, Lidington D, and Wilson JX. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol 90: 795-803, 2001.
3. Asplin Jr. Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31: 927-949, 2001.
4. Barreiro E, Comtois AS, Gea J, Laubach VE, and Hussain SN. Protein tyrosine nitration in the ventilatormuscles: role of nitric oxide synthases. Am J Respir CellMol Biol 26: 438-446, 2002.
5. Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, and Chiolero RL. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care 12: R101, 2008.
6. Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J, and Suter PM. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 24: 392-397, 1996.
7. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, and Regnier B. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274: 968-974, 1995.
8. Buras JA, Holzmann B, and Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4: 854-865, 2005.
9. Carr AC and Frei B. Human neutrophils oxidize low-density lipoprotein by a hypochlorous acid-dependent mechanism: the role of vitamin C. Biol Chem 383: 627-636, 2002.
10. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, and Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A 105: 11105-11109, 2008.
11. Collier BR, Giladi A, Dossett LA, Dyer L, Fleming SB, and Cotton BA. Impact of high-dose antioxidants on outcomes in acutely injured patients. JPEN J Parenter Enteral Nutr 32: 384-388, 2008.
12. Deubzer B, Mayer F, Kuçi Z, Niewisch M, Merkel G, Handgretinger R, and Bruchelt G. H(2)O(2)-mediated cytotoxicity of pharmacologic ascorbate concentrations to neuroblastoma cells: potential role of lactate and ferritin. Cell Physiol Biochem 25: 767-774, 2010.
13. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, and Nelson DR. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 33: 341-348, 2005.
14. Du J, Cullen JJ and Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 1826: 443-457, 2012.
15. Dwenger A, Pape HC, Bantel C, Schweitzer G, Krumm K, Grotz M, Lueken B, Funck M, and Regel G. Ascorbic acid reduces the endotoxin-induced lung injury in awake sheep. Eur J Clin Invest 24: 229-235, 1994.
16. Ellis GR, Anderson RA, Lang D, Blackman DJ, Morris RH, Morris-Thurgood J, McDowell IF, Jackson SK, Lewis MJ, and Frenneaux MP. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short-and long-term vitamin C therapy. J Am Coll Cardiol 36: 1474-1482, 2000.
17. Fisher BJ, Seropian IM, Kraskauskas D, Thakkar JN, Voelkel NF, Fowler AA 3rd, and Natarajan R. Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury. Crit Care Med 39: 1454-1460, 2011.
18. Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Wegelin JA, Brophy D, Ward KR, Voelkel NF, Fowler AA 3rd, and Natarajan R. Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. Am J Physiol Lung Cell Mol Physiol 303: L20-L32, 2012.
19. Galley HF, Davies MJ, and Webster NR. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 20: 139-143, 1996.
20. Galley HF, Davies MJ, and Webster NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 24: 1649-1653, 1996.
21. Galley HF, Howdle PD, Walker BE, and Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 23: 768-774, 1997.
22. Gaut JP, Belaaouaj A, Byun J, Roberts LJ 2nd, Maeda N, Frei B, and Heinecke JW. Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation. Free Radic Biol Med 40: 1494-1501, 2006.
23. Goldman D, Bateman RM, and Ellis CG. Effect of sepsis on skeletal muscle oxygen consumption and tissue oxygenation: interpreting capillary oxygen transport data using a mathematical model. Am J Physiol Heart Circ Physiol 287: H2535-H2544, 2004.
24. Han M, Pendem S, Teh SL, Sukumaran DK, Wu F, and Wilson JX. Ascorbate protects endothelial barrier function during septic insult: Role of protein phosphatase type 2A. Free Radic Biol Med 48: 128-135, 2010.
25. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, and Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276: 40-47, 2001.
26. Helling H, Schenk HJ, Pindur G, Weinrich M, Wagner B, and Stephan B. Fibrinolytic and procoagulant activity in septic and haemorrhagic shock. Clin Hemorheol Microcirc 45: 295-300, 2010.
27. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, and Day AG; Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368: 1489-1497, 2013.
28. Hirase T, Kawashima S, Wong EY, Ueyama T, Rikitake Y, Tsukita S, Yokoyama M, and Staddon JM. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and-independent mechanisms. J Biol Chem 276: 10423-10431, 2001.
29. Hollenberg SM, Guglielmi M, and Parrillo JE. Discordance between microvascular permeability and leukocyte dynamics in septic inducible nitric oxide synthase deficient mice. Crit Care 11: R125, 2007.
30. Hyslop PA, Hinshaw DB, Scraufstatter IU, Cochrane CG, Kunz S, and Vosbeck K. Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense. Free Radic Biol Med 19: 31-37, 1995.
31. Kallio J, Jaakkola M, Ma ki M, Kilpelainen P, and Virtanen V. Vitamin C inhibits Staphylococcus aureus growth and enhances the inhibitory effect of quercetin on growth of Escherichia coli in vitro. Planta Med 78: 1824-1830, 2012.
32. Ladurner A, Schmitt CA, Schachner D, Atanasov AG, Werner ER, Dirsch VM, and Heiss EH. Ascorbate stimulates endothelial nitric oxide synthase enzyme activity by rapid modulation of its phosphorylation status. Free Radic Biol Med 52: 2082-2090, 2012.
33. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, and Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 40: 754-761, 2012.
34. Lee WL and Slutsky AS. Sepsis and endothelial permeability. N Engl J Med 363: 689-691, 2010.
35. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, Franks W, Lawson TC, and Sauberlich HE. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 109: 144-148, 2003.
36. Martin GS, Mannino DM, Eaton S, and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554, 2003.
37. May JM and Qu ZC. Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid. Biochem Biophys Res Commun 404: 701-705, 2011.
38. Mu hlho fer A, Mrosek S, Schlegel B, Trommer W, Rozario F, Bo hles H, Schremmer D, Zoller WG, and Biesalski HK. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers. Eur J Clin Nutr 58: 1151-1158, 2004.
39. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, and Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236: 814-822, 2002.
40. Nin N, El-Assar M, Sánchez C, Ferruelo A, Sánchez-Ferrer A, Mart́nez-Caro L, Rojas Y, Paula M, Hurtado J, Esteban A, and Lorente JA. Vascular dysfunction in sepsis: effects of the peroxynitrite decomposition catalyst MnTMPyP. Shock 36: 156-161, 2011.
41. Nunbhakdi-Craig V, Machleidt T, Ogris E, Bellotto D, White CL 3rd, and Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 158: 967-978, 2002.
42. Ohama T and Brautigan DL. Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J Biol Chem 285: 8711-8718, 2010.
43. Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, and Levine M. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 5: e11414, 2010.
44. Peng ZY, Wang HZ, Srisawat N, Wen X, Rimmelé T, Bishop J, Singbartl K, Murugan R, and Kellum JA. Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis. Crit Care Med 40: 538-543, 2012.
45. Raeven P, Feichtinger GA, Weixelbaumer KM, Atzenhofer S, Redl H, Van Griensven M, Bahrami S, and Osuchowski MF. Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcome of murine polymicrobial sepsis. Thromb Res 129: e238-e245, 2012.
46. Ranzato E, Biffo S, and Burlando B. Selective ascorbate toxicity in malignant mesothelioma: a redox Trojan mechanism. Am J Respir Cell Mol Biol 44: 108-117, 2011.
47. Reagan-Shaw S, Nihal M, and Ahmad N. Dose translation from animal to human studies revisited. FASEB J 22: 659-661, 2008.
48. Robitaille L, Mamer OA, Miller WH, Jr., Levine M, Assouline S, Melnychuk D, Rousseau C, and Hoffer LJ. Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism 58: 263-269, 2009.
49. Sakr Y, Dubois MJ, De Backer D, Creteur J, and Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32: 1825-1831, 2004.
50. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, and Bodenham A. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 63: 760-765, 1996.
51. Secor D, Li F, Ellis CG, Sharpe MD, Gross PL, Wilson JX, and Tyml K. Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med 36: 1928-1934, 2010.
52. Sharma P, Raghavan SA, Saini R, and Dikshit M. Ascorbatemediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide. J Leukoc Biol 75: 1070-1078, 2004.
53. Shen KP, Lo YC, Yang RC, Liu HW, Chen IJ, and Wu BN. Antioxidant eugenosedin-A protects against lipopolysaccharide-induced hypotension, hyperglycaemia and cytokine immunoreactivity in rats and mice. J Pharm Pharmacol 57: 117-125, 2005.
54. Shostak A and Gotloib L. Increased mesenteric, diaphragmatic, and pancreatic interstitial albumin content in rats with acute abdominal sepsis. Shock 9: 135-137, 1998.
55. Solomkin JS and Mazuski J. Intra-abdominal sepsis: newer interventional and antimicrobial therapies. Infect Dis Clin North Am 23: 593-608, 2009.
56. Spada PL, Rossi C, Alimonti A, Bocca B, Cozza V, Ricerca BM, Bocci MG, Vulpio C, and De Sole P. Ferritin iron content in haemodialysis patients: comparison with septic and hemochromatosis patients. Clin Biochem 41: 997-1001, 2008.
57. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, and Shimazaki S. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch Surg 135: 326-331, 2000.
58. Tyml K, Li F, and Wilson JX. Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med 33: 1823-1828, 2005.
59. Tyml K, Li F, and Wilson JX. Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med 36: 2355-2362, 2008.
60. Vianna RC, Gomes RN, Bozza FA, Amâ ncio RT, Bozza PT, David CM, and Castro-Faria-Neto HC. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release. Shock 21: 115-120, 2004.
61. Vincent JL, Nelson DR, and Williams MD. Is worsening multiple organ failure the cause of death in patients with severe sepsis Crit Care Med 39: 1050-1055, 2011.
62. Wu F and Wilson JX. Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovasc Res 81: 38-45, 2009.
63. Wu F, Wilson JX, and Tyml K. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol 285: R50-R56, 2003.
64. Wu F, Wilson JX, and Tyml K. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radic Biol Med 37: 1282-1289, 2004.
65. Wu F, Tyml K, and Wilson JX. iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J Cell Physiol 217: 207-214, 2008.
66. Wu F, Han M, and Wilson JX. Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation. Br J Pharmacol 157: 1014-1023, 2009.
67. Yamazaki E, Horikawa M, and Fukushima R. Vitamin C supplementation in patients receiving peripheral parenteral nutrition after gastrointestinal surgery. Nutrition 27: 435-439, 2011.
68. Zhou G, Kamenos G, Pendem S, Wilson JX, and Wu F. Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis. Am J Physiol Regul Integr Comp Physiol 302: R409-R416, 2012. Medicine